News analysis

Geopolitics, domestic sentiment shape region's Covid-19 vaccine race

A man preparing to spray disinfectant around Klong Toey fresh market, after it was temporarily shut down due to several vendors testing positive for Covid-19, in Bangkok on Jan 14, 2021. PHOTO: AFP
New: Gift this subscriber-only story to your friends and family

BANGKOK - Thailand looked like it was ahead in the regional scramble for a coronavirus vaccine in October when it announced a local firm would manufacture the Oxford-AstraZeneca vaccine for domestic use and distribution to nearby countries.

But with a locally-produced vaccine months away while local transmissions grew over the new year, Thailand sought to boost its initial reservation of 26 million doses. It ordered 35 million more, and supplemented that with two million doses of vaccine from China's Sinovac Biotech. The first batches of British and Chinese-made vaccines are expected to arrive next month.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.